Novartis' New Heart Failure Medicine Entresto Receives CHMP Recommendation for EU Approval
September 25, 2015 at 04:31 AM EDT
Novartis (NYSE: NVS) announced today that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for ...
